This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
DASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity and Chronic Conditions | MicrobiomeTrials
← Back to trials NCT07638345
DASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity and Chronic Conditions Recruiting NA INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2025-10-30Est. Completion: 2026-03-27
Enrollment target: 280 participantsLocations Adhera Health (Virtual Participation), Seville, Spain Other microbiome trials you might be interested in SARS-CoV-2 Influenza, Human Respiratory Syncytial Virus Infections Respiratory Distress Syndrome Systemic Inflammatory Response Syndrome
The purpose of this clinical trial is to evaluate the safety, tolerability and efficacy of two doses (dose A and dose B)…
Alcalá de Henares, Spain Est. completion Oct 2, 2026
Nephrotic Syndrome in Children Focal Segmental Glomerulosclerosis Minimal Change Disease Minimal Change Nephrotic Syndrome
Membranous Nephropathy
FSGS
MCD
MCD - Minimal Change Disease
Alport Syndrome
NEPTUNE Match is an additional opportunity offered to NEPTUNE study participants to prospectively recruit and communicat…
Atlanta, United States Est. completion Dec 30, 2029
Fatty Liver
The newly adapted definition for MASLD includes evidence for hepatic steatosis by imaging or biopsy with at least one of…
Sohag, Egypt Est. completion Jan 1, 2027